Back to search

Article

Incidence of Guillain-Barré syndrome following SARS-CoV-2 immunization in Mexico: A nation-wide registry of seven COVID-19 vaccines

2022-04-12

Abstract excerpt

<h4>Summary</h4> <h4>Background</h4> Guillain-Barré syndrome (GBS) as an adverse event following immunization (AEFI) against SARS-CoV-2 has been linked to a few (ChAdOx1 nCov-19 and Ad26.COV2-S), but not all vaccines, including mRNA-based ones. Epidemiological information on GBS among recipients of other SARS-CoV-2-directed vaccines among Latinx/Hispanic recipients is scarce. <h4>Methods</h4> We report GBS inciden...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f598fe55-5555-5b5d-958c-57f01e39aa12
DOI
10.1101/2022.04.11.22273754
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Incidence of Guillain-Barré syndrome following SARS-CoV-2 immunization in Mexico: A nation-wide registry of seven COVID-19 vaccinesDOI 10.1101/2022.04.11.22273754
Select a neighboring publication to make it the new centre.